Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial.
- Published in:
- Pediatric Drugs, 2019, v. 21, n. 4, p. 291, doi. 10.1007/s40272-019-00332-y
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2019 AND VI 21 AND IP 4
Results: 8
1
2
Annual European Congress of Rheumatology: Madrid, Spain, 12–15 June 2019.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
3
Facilitating Informed Permission/Assent/Consent in Pediatric Clinical Trials.
- Published in:
- Pediatric Drugs, 2019, v. 21, n. 4, p. 205, doi. 10.1007/s40272-019-00347-5
- By:
- Publication type:
- Article
4
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives.
- Published in:
- Pediatric Drugs, 2019, v. 21, n. 4, p. 215, doi. 10.1007/s40272-019-00345-7
- By:
- Publication type:
- Article
5
Botulinum Toxin in the Management of Children with Cerebral Palsy.
- Published in:
- Pediatric Drugs, 2019, v. 21, n. 4, p. 261, doi. 10.1007/s40272-019-00344-8
- By:
- Publication type:
- Article
6
Vancomycin Use in a Paediatric Intensive Care Unit of a Tertiary Care Hospital.
- Published in:
- Pediatric Drugs, 2019, v. 21, n. 4, p. 303, doi. 10.1007/s40272-019-00343-9
- By:
- Publication type:
- Article
7
New and Emerging Therapies for Pediatric Atopic Dermatitis.
- Published in:
- Pediatric Drugs, 2019, v. 21, n. 4, p. 239, doi. 10.1007/s40272-019-00342-w
- By:
- Publication type:
- Article
8
Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
- Published in:
- Pediatric Drugs, 2019, v. 21, n. 4, p. 283, doi. 10.1007/s40272-019-00341-x
- By:
- Publication type:
- Article